methylcobalamin increased cellular levels of B12 and filled the bodys store of the vitamin
This integrated tri-agonist approach produces synergistic metabolic effects that cannot be achieved with other research peptides: Source: Jastreboff et al., New England Journal of Medicine, 2023 Source: Killion et al., Nature Metabolism, 2022 Source: U.S
BPC157 showed linear pharmacokinetic characteristics in beagle dogs at the experimental dose
However, most patients experience appetite suppression within 1-4 weeks, and weight loss starts after 4 weeks
Indication: Specifically for vitamin B12 deficiency due to supplemental insufficiency, certain anemias, gastrointestinal malabsorption, and neurological conditions associated with low B12 levels